神经介入溶栓术治疗急性脑梗死的临床疗效及对患者血清NSE、S-100β及神经生长因子的影响.pdf

海南医学2021年6月第32卷第11期 Hainan Med J, Jun. 2021, Vol. 32, No. 11AO Yan-chun 2, WANG Na 1, WANG
Wen-zong 1, MA Xing-shun 1. 1. Department of Neurology, the First Hospital of Yulin, Yulin 719000, Shaanxi, CHINA; 2.
Department of General Surgery, Beiwan Town Central Health Center of Jingyuan County, Baiyin 730605, Gansu, CHINA
【Abstract】 Objective To observe the clinical efficacy of neurointerventional thrombolysis in the treatment of
acute cerebral infarction (ACI) and explore its effects on serum neuron-specific enolase (NSE), S-100 β, and nerve
growth factor (NGF) of patients. Methods A total of 104 patients with ACI who admitted to the First Hospital of Yulin
from January 2018 to June 2020 were selected as the research subjects, and they were divided into observation group and
control group by random number table method, with 52 patients in each group. The control group was given intravenous
thrombolysis, and the observation group was given neurointerventional thrombolysis. The clinical treatment effect after
thrombolysis, as well as National Institutes of Health Stroke Scale (NIHSS) score, and levels of serum NSE, S-100β,
and NGF before and after thrombolysis were compared between the two groups. Results The total